124 related articles for article (PubMed ID: 3872170)
1. Phase II trial of diaziquone in advanced ovarian carcinoma. European Organization for Research on Treatment of Cancer Early Clinical Trials Group.
Lund B; Bramwell V; Renard J; Hansen HH; Dombernowsky P
Cancer Treat Rep; 1985 Mar; 69(3):339-40. PubMed ID: 3872170
[No Abstract] [Full Text] [Related]
2. Phase II clinical trial of diaziquone in the treatment of patients with epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Slayton RE; Blessing JA; Sutton GP; Homesley HD; Park R
Cancer Treat Rep; 1986 Feb; 70(2):309-10. PubMed ID: 3948196
[No Abstract] [Full Text] [Related]
3. Phase II trial of diaziquone in advanced upper aerodigestive cancer.
Creagan ET; Long HJ; Kvols LK; Edmonson JH; O'Fallon JR
Cancer Treat Rep; 1985 Jan; 69(1):141. PubMed ID: 3967258
[No Abstract] [Full Text] [Related]
4. Phase II clinical trial of diaziquone in bronchogenic carcinoma.
Chiuten DF; Umsawasdi T; Dhingra HM; Murphy WK; Spitzer G; Carr DT; Bodey GP; Valdivieso M
Cancer Treat Rep; 1985; 69(7-8):921-2. PubMed ID: 4016800
[No Abstract] [Full Text] [Related]
5. Phase II trial of diaziquone in advanced large bowel carcinoma in previously treated and untreated patients: a Southwest Oncology Group Study.
Shildt R; Stephens RL; Subramanian VP; Baker LH; Fletcher WS; O'Bryan RM; McCracken JD
Cancer Treat Rep; 1985 Jun; 69(6):709-10. PubMed ID: 4016775
[No Abstract] [Full Text] [Related]
6. Phase II study of aclarubicin and diaziquone in the treatment of advanced small cell bronchogenic carcinoma (EST 4581): an Eastern Cooperative Oncology Group Study.
Abeloff MD; Finkelstein DM; Chang AY; Camacho FJ; Creech RH; Ettinger DS
Cancer Treat Rep; 1985 Apr; 69(4):451-2. PubMed ID: 3857972
[No Abstract] [Full Text] [Related]
7. Phase II study of diaziquone in patients with advanced carcinoma of the lung.
Frytak S; Eagan RT; Creagan ET; Nichols WC
Cancer Treat Rep; 1984 Sep; 68(9):1193-4. PubMed ID: 6478455
[No Abstract] [Full Text] [Related]
8. Phase II trial of diaziquone in anthracycline-resistant adult soft tissue and bone sarcoma patients: a Southeastern Cancer Study Group Trial.
Chan C; Bartolucci A; Brenner D; Presant C; Davila E; Carpenter J; Greco FA; Clamon G; Moore J
Cancer Treat Rep; 1986 Mar; 70(3):427-8. PubMed ID: 3456834
[No Abstract] [Full Text] [Related]
9. Phase II evaluation of diaziquone in recurrent head and neck cancer.
Kish JA; Ensley J; Al-Sarraf M
Cancer Treat Rep; 1986 May; 70(5):671-2. PubMed ID: 3708616
[No Abstract] [Full Text] [Related]
10. Phase II trial of diaziquone in malignant mesothelioma.
Eagan RT; Frytak S; Richardson RL; Creagan ET; Nichols WC
Cancer Treat Rep; 1986 Mar; 70(3):429. PubMed ID: 3955559
[No Abstract] [Full Text] [Related]
11. Phase II study of diaziquone in advanced soft tissue and bony sarcoma: a Southwest Oncology Group study.
Zidar BL; Baker LH; Rivkin SE; Balcerzak SP; Stephens RL
Cancer Treat Rep; 1985 Sep; 69(9):1035-6. PubMed ID: 4028037
[No Abstract] [Full Text] [Related]
12. Phase II evaluation of diaziquone in pancreatic carcinoma: a Southwest Oncology Group Study.
Tilchen EJ; Fleming T; Mills G; Oishi N; Bonnett JD; Natale RB; Harker G; Coltman CA
Cancer Treat Rep; 1987 Dec; 71(12):1309-10. PubMed ID: 3690548
[No Abstract] [Full Text] [Related]
13. Phase II trial of diaziquone in advanced renal adenocarcinoma.
Hansen M; Gallmeier WM; Vermorken J; Holdener E; Hansen HH; Renard J; Rozencweig M
Cancer Treat Rep; 1984; 68(7-8):1055-6. PubMed ID: 6744342
[No Abstract] [Full Text] [Related]
14. Phase I-II diaziquone chemotherapy in brain tumors.
Madajewicz S; Spaulding M; Bhimani S; Avellanosa A; DeLos Santos R; Perry A; Zeigler P; Kirshner J
Cancer Treat Rep; 1984 Jun; 68(6):913-4. PubMed ID: 6733706
[No Abstract] [Full Text] [Related]
15. Phase II trials of the single agents baker's antifol, diaziquone, and epirubicin in advanced pancreatic cancer. Gastrointestinal Tumor Study Group.
Cancer Treat Rep; 1987 Sep; 71(9):865-7. PubMed ID: 3476203
[No Abstract] [Full Text] [Related]
16. Phase II trial of diaziquone in patients with colon cancer.
Neidhart JA; Erlichman C; Robert F; Velez-Garcia E; Bender JF; Grillo-López J
Cancer Treat Rep; 1985 Feb; 69(2):215-7. PubMed ID: 3882229
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of aziridinylbenzoquinone (AZQ) in head and neck cancer.
Forastiere AA; Crain SM; Callahan K; Van Echo D; Mattox D; Thant M; Von Hoff DD; Wiernik PH
Cancer Treat Rep; 1982 Dec; 66(12):2097-8. PubMed ID: 6892491
[No Abstract] [Full Text] [Related]
18. Phase II trial of diaziquone in patients with refractory and relapsing multiple myeloma: a Southwest Oncology Group Study.
Stuckey WJ; Crowley J; Baker LH; Larrimer NR; Hanson KH; Bonnet JD; White LA
Cancer Treat Rep; 1987 Nov; 71(11):1095-6. PubMed ID: 3119202
[No Abstract] [Full Text] [Related]
19. Cancer and leukemia group B phase II non-small cell lung carcinoma trial: aziridinylbenzoquinone (AZQ).
Carey RW; Comis RL; Anbar D; Kennedy BJ; Capizzi RL; Shulman P; Booth BW; Green M; Raich PC
Cancer Treat Rep; 1983 Jan; 67(1):95-6. PubMed ID: 6616498
[No Abstract] [Full Text] [Related]
20. Diaziquone for resistant multiple myeloma. Cancer and Leukemia Group B.
Vinciguerra V; Anderson K; McIntyre OR
Cancer Treat Rep; 1985 Mar; 69(3):331-2. PubMed ID: 3884154
[No Abstract] [Full Text] [Related]
[Next] [New Search]
